Predict your next investment

Stemgenics company logo
HEALTHCARE | Biotechnology
stemgenics.com

See what CB Insights has to offer

Stage

Unattributed - III | Alive

Total Raised

$3.35M

Last Raised

$450K | 3 yrs ago

About Stemgenics

Stemgenics is a growing nano-biotechnology company focused on generation of personalized human stem cells and more differentiated specialized cell types for biomedical research and pre-clinical/clinical applications.

Stemgenics Headquarter Location

454 N 34th Street Suite 100

Seattle, Washington, 98103,

United States

206-676-7000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Stemgenics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Stemgenics is included in 2 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Stemgenics Patents

Stemgenics has filed 5 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • Cell biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/22/2012

6/13/2017

Transcription factors, Stem cells, Biotechnology, Nanotechnology, Developmental biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/22/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/13/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Stem cells, Biotechnology, Nanotechnology, Developmental biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.